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Halogenation is a frequent modification of secondary metabolites and can play a significant role in establish-
ing the bioactivity of a compound. Enzymatic halogenation through oxidative mechanisms is the most
common route to these metabolites, though direct halogenation via halide anion incorporation is also known
to proceed through both enzymatic and nonenzymatic pathways. In this article, we review the current state of
knowledge regarding the mechanisms of these transformations, highlight applications of this knowledge,
and propose future opportunities and challenges for the field.Introduction
Compounds containing carbon–halogen bonds constitute a
diverse group of natural products that display a wide range of
biological activities, including anticancer and antibiotic proper-
ties. Over 4000 halogenated products have been isolated from
natural sources (Gribble, 2004). Chlorination is the predominant
modification, followed by bromination, while iodination and fluo-
rination are rare in Nature. Examples of halogenated natural
products include the remarkably potent anticancer agents
b-lactone salinosporamide A, macrocyclic lactone polyether
spongistatin, indolocarbazole rebeccamycin, and enediyne
calicheamicin g1
I, and a number of antibiotics, such as vancomy-
cin, chlortetracycline, and chloramphenicol (Fenical and Jensen,
2006; Gribble, 1998, 2004; Nicolaou et al., 1993).
The presence of halogen substituents in many natural prod-
ucts profoundly influences their biological activity (Figure 1).
For example, two chlorine substituents in vancomycin, the anti-
biotic of last resort for the treatment of multiple-drug resistant S.
aureus infections, are required to achieve the clinically active
conformation of this antibiotic through the control of atropisomer
distribution (Harris et al., 1985). The therapeutic efficacy of sali-
nosporamide A, a proteasome inhibitor currently in clinical trials
for multiple myeloma treatment, requires the presence of a chlo-
rine substituent. Addition of the hydroxyl moiety of the protea-
some’s active site threonine into the lactone of salinosporamide
leads to opening of the b-lactone and release of the free hydroxyl
group in this molecule. This nucleophilic hydroxyl, capable of
reforming the lactone and releasing the inhibitor, instead reacts
in an intramolecular fashion to displace the primary chloride sub-
stituent and form a tetrahydrofuran ring (Groll et al., 2006). The
two-reaction sequence provides for an irreversible covalent inhi-
bition and underlies the potency of this anticancer agent. The
presence of a chloride substituent is also relevant for the biolog-
ical activity of rebeccamycin: in contrast to rebeccamycin, its
deschloro derivatives lack antimicrobial activity (Rodrigues
Pereira et al., 1996). Similarly, the halogenated sesterterpenes
neomangicol A and B show in vitro cytotoxic effect toward
HCT-116 human colon tumor cell line, while their nonhaloge-
nated analog neomangicol C was inactive in this assay (Renner
et al., 1998).Chemistry &Given the vital role that halogens can play in determining the
biological activity of secondary metabolites, their biosynthesis
has been a topic of study for over 40 years. In the last decade,
the cloning and sequencing of biosynthetic gene clusters has
revealed new chemistries for halogen incorporation and pro-
vided a driving force for detailed mechanistic studies of these
enzymes. A combination of biochemical, spectroscopic, and
structural characterizations has provided ever more detailed
insights into the workings of these catalysts. In return, the knowl-
edge gained is being used to facilitate the identification of new
natural products and gene clusters while enabling the metabolic
engineering of novel metabolites.
Halogenation by Hypohalite, X+
The first general strategy for enzymatic halogenation is to gener-
ate a reactive hypohalite species by two-electron oxidation of the
corresponding halide. Consistent with the electronic deficient
nature of the hypohalite, this strategy is used by Nature to haloge-
nate electron-richcarbon centers innatural products.Thespecific
oxidant distinguishes the two broad classes of halogenating
enzymes. Hydrogen peroxide is used by the haloperoxidase
class,whereas molecular oxygen is used by the halogenase class.
Heme-Fe Haloperoxidases
The first halogenating enzyme to be characterized, chloroperox-
idase (CPO) from Caldariomyces fumago, serves as the proto-
typical heme-iron haloperoxidase. The protein was isolated
based on its postulated involvement in the biosynthesis of the
natural product caldariomycin. CPO was shown to dichlorinate
the activated carbon of 1,3-cyclopentanedione and halogenate
other electron rich carbons including the b-carbon of dimedone
and the 3- and 5- positions of the amino acid tyrosine (Hager
et al., 1966). CPO also catalyzes a host of related reactions,
including oxidation of iodide to iodine, sulfoxidation of dialkyl
sulfides, P450-like insertion of oxygen into C–H s-bonds and
C–C p-bonds, and catalase-like disproportionation of hydrogen
peroxide into oxygen and water (van Rantwijk and Sheldon,
2000). This broad range of chemistry coupled with the protein’s
stability have made it of interest for commercial applications.
The proposed mechanism for halogenation (Figure 2A)
involves the initial binding of peroxide at the axial position ofBiology 15, February 2008 ª2008 Elsevier Ltd All rights reserved 99
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intermediate FeIV–oxo species known as compound I which is then
intercepted by halide to form a FeIII–hypohalite species.
Halogenation of the organic substrate can proceed directly from
this compound, or alternatively free hypohalous acid can be re-
leased and perform the actual halogenation more distant from the
Fe center. Given the acidic conditions in which CPO works best
and the general lack of substrate specificity, it is widely believed
that free hypohalous acid is the dominant halogenating agent.
Structurally, CPO appears to blend characteristics of the
cytochrome P450 enzymes and heme peroxidases. Spectro-
scopic (Dawson and Sono, 1987) and structural studies (Sundar-
amoorthy et al., 1995) confirmed that, as in P450s, the proximal
axial ligand to the catalytic iron is thiolate derived from a cysteine
side chain. The distal binding pocket is more reminiscent of
heme peroxidases in that it is composed primarily of polar amino
acid side chains. Partially occupied binding sites for bromide and
iodide were found near a channel from the protein’s surface to
the Fe center, and these may provide transient sites to guide
the halide ion to the catalytic center. When the substrate 1,3-
cyclopentanedione was soaked in at high concentrations, the
compound was observed to bind directly above the heme
center. Unfortunately, the orientation of the substrate and its
too-close proximity to the active site suggest that the observed
interaction is not productive for catalytic purposes.
Vanadium-Dependent Haloperoxidases
Studies of halogenation in marine natural products identified
a second subclass of haloperoxidases that contained vanadium
as the necessary cofactor. These vanadium-dependent haloper-
oxidases (V-HPO) are thought to be responsible for the vast
majority of halogenation events in marine natural products.
Vanadium-dependent bromoperoxidases (V-BPO) are widely
distributed throughout marine seaweeds (Butler and Carter-
Franklin, 2004) while the vanadium-dependent chloroperoxidases
Figure 1. Representative Natural Products with Halogen-Dependent
Bioactivity
Figure 2. Oxidative Halogenation by
Haloperoxidases
(A) Formation of hypochlorous acid by heme
Fe-dependent chloroperoxidase.
(B) Formation of vanadium-bound hypobromite by
V-BPO.
(C) Chloronium-mediated cyclizations catalyzed
by V-CPOs to produce a chlorinated napyradio-
mycin derivative. The chlorine on the benzoqui-
none core is likely incorporated via a flavin-depen-
dent halogenase.100 Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved
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terial species (Winter et al., 2007).
Like the heme-iron haloperoxidases, the metal center of
V-HPO binds hydrogen peroxide and activates it for attack by
halide (Figure 2B). However, the vanadium atom does not appear
to be redox active, instead maintaining its V(V) oxidation state
throughout the catalytic cycle. Peroxide binds to provide an acti-
vated h2-peroxo intermediate, whereupon bromide reacts to
form vanadium-bound hypobromite. Again, it is not clear if this
bound intermediate is the active oxidizing agent, or if hypobro-
mous acid is released from the metal center before bromination
occurs. Structural studies of V-BPO (Isupov et al., 2000; Weyand
et al., 1999) and V-CPO (Messerschmidt and Wever, 1996) show
large differences in the overall structure, but a highly similar active
site that supports the proposed mechanism. The vanadate ion
sits at the bottom of a wide substrate funnel and is coordinated
to the protein via a conserved histidine residue. When cocrystal-
lized with azide—a known inhibitor of V-CPO— the ion displaces
the water opposite the histidine suggesting this is the site of initial
coordination of peroxide (Messerschmidt and Wever, 1996).
The reactions catalyzed by V-HPO generally proceed through
halonium intermediates. Complex molecules can be formed
when the initial halonium ion is intercepted by intramolecular
nucleophiles including hydroxyl groups and p-bonds. Recently,
three genes with homology to vanadium-dependent chloroperox-
idases were found in the napyradiomycin gene cluster of Strepto-
Figure 3. Chemistry of Flavin-Dependent
Halogenases
(A) Regioselective chlorination of tryptophan by
FAD-dependent halogenases and dichlorination
of pyrrolyl-S-PltL by PltA.
(B) Mechanism of halogenation by RebH. Flavin-
generated hypochlorous acid is trapped by the
enzyme as lysine chloramine before tryptophan
halogenation.
myces aculeolatus NRRL 18422 and
Streptomyces sp. CNQ-525 (Winter et al.,
2007). Two of the enzymes, NapH1 and
NapH4, are proposed to play a role in the
oxidative cyclizations of two terpene-de-
rived side chains on the dihydroquinone
core (Figure 2C). In one case, the chloro-
nium ion is quenched by addition of an in-
tramolecular hydroxyl group; in the other,
the chloronium ion is first intercepted by
a p-bond and the resulting carbonium ion
is quenched by water. The third enzyme,
NapH3, is suggested to be a hydroxylase
based on the absence of a key active site
residue necessary for haloperoxidase ac-
tivity. These genes are the first example
of V-HPOs in bacterial species as well as
the first to be placed in the context of
a dedicated biosynthetic gene cluster.
Given the highly similar reactions per-
formed on a common molecular structure,
biochemical characterization of these enzymes will provide
a unique opportunity to address questions of selectivity within
this class of enzymes.
Flavin-Dependent Halogenases
Enzymatic halogenation via hypohalitecan alsobe catalyzed using
molecular oxygen as the oxidant with flavin as the redox active
cofactor. The first halogenase, PrnA, was described in 2000 (Keller
et al., 2000) and since that time a number of related family mem-
bers have been purified and characterized (Figure 3A). These
genes are commonly found within microbial biosynthetic gene
clusters and the enzymes catalyze specific halogenation events
in the biosynthetic pathways. PrnA catalyzes the conversion of
free tryptophan to 7-chlorotryptophan during the biosynthesis of
pyrrolnitrin. The identical transformation to 7-chlorotryptophan is
catalyzed by RebH in the biosynthesis of the indolocarbazole nat-
ural product rebeccamycin (Yeh et al., 2005). In each case, the
reaction was shown to be dependent on the reduced flavin cofac-
tor, oxygen, and chloride ion. Additionally, an NAD(P)H-dependent
flavin reductase is necessary to reduce the oxidized cofactor; for
PrnA a general reductase is recruited from cellular metabolism
whereas for RebH a dedicated reductase (RebF) is encoded in
the biosynthetic gene cluster. Halogenases for the 5- and 6-
positions of tryptophan have also been described for the biosyn-
theses of pyrroindomycin (Zehner et al., 2005) and thienodolin
(van Pee and Zehner, 2003), respectively. That these homologous
enzymes each produce only a single chlorotryptophan isomerChemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved 101
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halogenases.
Amino acids are also known to be halogenated when bound
to the peptidyl carrier proteins found in nonribosomal peptide
synthase assembly lines. In the biosynthesis of pyoluteorin,
thiolation domain-bound proline (prolyl-S-PltL) is oxidized to
pyrrolyl-S-PltL (Thomas et al., 2002). This electron-rich aromatic
variant is then doubly chlorinated at C5 and C4 by the halogen-
ase PltA (Dorrestein et al., 2005). SgcC3 was recently shown to
catalyze the selective chlorination of the C3 position of b-tyro-
syl-S-SgcC2 during the biosynthesis of the enediyne antibiotic
C-1027 (Lin et al., 2007).
A series of structural, spectroscopic, and biochemical studies
has helped to refine the proposed mechanism for flavin halo-
genases (Figure 3B). The crystal structures of PrnA (Dong et al.,
2005) and RebH (Yeh et al., 2007) show the expected flavin bind-
ing domain with a chloride ion bound in a pocket on the solvent-
protected face of the cofactor. This binding module is similar to
those in known flavin monooxygenases and initial reaction of
reduced flavin with molecular oxygen is thought to proceed via
the same mechanism to provide a flavin hydroperoxide (FAD-
C4a-OOH) intermediate (Entsch and van Berkel, 1995). The struc-
ture also shows that the tryptophan binding pocket is located 10A˚
away from the flavin cofactor with only a narrow channel connect-
ing the two sites, excluding direct interaction between the
substrate and oxidized flavin (either FAD-C4a-OOH or FAD-C4a-
OCl). Instead it is proposed that chloride attack on the distal
oxygen of FAD-C4a-OOH produces enzyme-trapped HOCl that
can diffuse toward the substrate binding site. Spectroscopic
and kinetic studies of RebH (Yeh et al., 2006) support this view
by showing that flavin redox chemistry is complete before sub-
strate halogenation. Furthermore, the redox chemistry can occur
in the absence of substrate proving that chloride oxidation by fla-
vin and substrate oxidation are uncoupled processes.
While free hypohalous acid would be a powerful enough oxidant
to perform the observed reactions, it is also known to react with
chemical functionalities within proteins. In addressing this ques-
tion of how flavin-dependent halogenases control this reactive
species toachieve selective substrate halogenation, itwas discov-
ered that the competent oxidizing species in the reaction has
a half-life of 28 hr (Yeh et al., 2007). When Na36Cl was used as
the chlorine source, the radiolabel was found to move sequentially
from chloride to protein to product. These data suggest the forma-
tion of a covalent adduct between the protein and chlorine. Based
on the known reactivity of lysine sidechains with hypochlorous
acid (Nightingale et al., 2000) and the strategic location of a con-
served lysine residue at the interface of the channel and substrate
pocket, it is proposed that Lys79 first reacts with the flavin-gener-
ated acid to produce a lysine chloramine species. With its attenu-
ated reactivity, the lysine chloramine is better suited to perform the
regioselective halogenation of the substrate. Thus, it appears that
Naturecovalentlycapturesan indiscriminatehalogenating reagent
(hypochlorous acid) within the protein to provide a less reactive but
more selective reagent (lysine chloramine) for the halogenation of
the substrate.
Halogenation via Halogen, X
Identificationof several halogenated naturalproducts, suchas the
trichlorinated marine molluscicide barbamide, produced by cya-102 Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rnobacterium Lyngbya majuscula (Orjala and Gerwick, 1996),
and Streptomyces armentosus-derived antibiotic armentomycin
(Argoudelis et al., 1967), revealed chlorine incorporation at unac-
tivated carbon centers. Such carbons are not amenable to mod-
ification by electrophilic agents, suggesting an entirely different
mechanism for carbon–halogen bond formation. A radical mech-
anism of chlorination was proposed to account for the regio- and
stereoselective conversion of pro-R methyl group of L-leucine
to the trichloromethyl moiety of barbamide (Hartung, 1999; Sita-
chitta et al., 1998). Recently, in vitro reconstitution and elucidation
of the mechanistic logic for halogenases capable of chlorinating
unactivated carbon centers has been achieved. Mononuclear
non-heme iron halogenases are imbedded in nonribosomal pep-
tide synthetase assembly lines, and act on the methyl groups of
thiolation domain-tethered amino acids (Figure 4A). Chlorination
of the methyl group of SyrB1-bound L-threonine in the biosynthe-
sis of the lipo-nonapeptidolactone syringomycin E is carried out
by a member of this class of enzymes, SyrB2 (Vaillancourt et al.,
2005b). Similarly, the halogenase CytC3 adds two chlorine atoms
to the terminal methyl group of L-2-aminobutyric acid (Aba) teth-
ered to thiolation domain CytC2 in biosynthesis of armentomycin
by soil Streptomyces sp. RK95-74 (Ueki et al., 2006). In vitro re-
constitution of the trichlorination event in barbamide biosynthesis
requires two halogenating enzymes, BarB1 and BarB2, which act
on L-Leu-S-BarA as a substrate (Galonic et al., 2006).
Detailed evaluation of cofactor requirements established that
ferrous iron, a-ketoglutarate (aKG), chloride, and oxygen are
required for enzymatic activity (Vaillancourt et al., 2005b), evok-
ing similarity with Fe(II)- and aKG-dependent dioxygenases. To
coordinate iron, dioxygenases of this class utilize aKG and three
protein residues, two histidine and one carboxylate (Asp or Glu),
in a characteristic His-x-Asp/Glu-xn-His ‘‘facial triad’’ sequence
(Costas et al., 2004; Hausinger, 2004; Que, 2000). A key catalytic
intermediate in the hydroxylation reaction is an Fe(IV)–oxo spe-
cies that abstracts hydrogen atom from the substrate to form
a substrate radical and an Fe(III)-OH species (Bollinger et al.,
2005; Hoffart et al., 2006). Subsequent transfer of the hydroxyl
group to the substrate radical—‘‘oxygen rebound’’—results in
the formation of an alcohol product. The X-ray crystal structure
of syringomycin halogenase SyrB2 shows that, in contrast to di-
oxygenases, the active site iron is coordinated by two protein-
derived histidine ligands (Blasiak et al., 2006). The carboxylate
residue is replaced by chloride, coordinated to iron opposite to
the C2 carbonyl moiety of aKG. In the primary sequence of
SyrB2, the conserved carboxylate of dioxygenases is replaced
by an alanine, resulting in His-x-Ala-xn-His motif. Sequence
alignment of known mononuclear non-heme iron halogenases
indeed confirms the presence of a conserved, sterically unde-
manding residue, such as Ala or Gly. The loss of the carboxylate
ligand and its replacement by exogenous halide is likely crucial
to the enzyme’s ability to bind and subsequently transfer halide
to organic substrate.
To evaluate if substrate activation proceeds through an analo-
gous Fe(IV)–oxo species, direct characterization of intermedi-
ates was carried out for the CytC3-catalyzed chlorination of
L-Aba-S-CytC2 (Figure 4B; Galonic et al., 2007). When the
starting CytC3-Fe(II)-aKG-Cl-L-Aba-S-CytC2 complex was
reacted with oxygen, accumulation of an intermediate state
with absorption feature characteristic of Fe(IV)–oxo intermediateights reserved
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the intermediate state using freeze-quench (FQ) Mo¨ssbauer
spectroscopy revealed that it consists of two rapidly equilibrat-
ing high-spin Fe(IV)–oxo species. To determine if these species,
in analogy to iron–oxo intermediates in dioxygenases, abstract
hydrogen atom from the substrate, d3-L-Aba-S-CytC2 was pre-
pared and subjected to spectroscopic analysis. Observed accu-
mulation of the intermediate state, as a result of a kinetic isotope
effect, suggests that the iron–oxo complexes in halogenases
catalyze C–H cleavage reaction to initiate substrate halogena-
tion. To obtain insight into the structure of the halogenation
intermediate, FQ Mo¨ssbauer and X-ray absorption studies
were performed on an intermediate trapped in the reaction of
CytC3-Fe(II)-aKG-Br-L-Aba-S-CytC2 complex with dioxygen
(Fujimori et al., 2007a). Extended X-ray absorption fine structure
spectroscopy (EXAFS) allowed for determination of iron–
bromide bond length in both control samples (2.53 A˚) and the
intermediate state obtained upon mixing with oxygen (2.43 A˚).
In addition, the intermediate also displayed a short iron–oxo
interaction (1.62 A˚), assigned to Fe(IV)–oxo species. The
obtained structural insights provide validation for the ligation of
halide to iron at the Fe(IV) intermediate stage of the catalytic
cycle and additional evidence for short iron–oxo interaction.
Thus, binding of dioxygen to Fe(II) in halogenases leads to the
formation of Cl-Fe(IV)–oxo species which activate the substrate
for halogenation via hydrogen atom abstraction to form sub-
strate radical and Cl-Fe(III)-OH intermediate.
Figure 4. Chemistry of Fe(II)/aKG-
Dependent Halogenases
(A) Representative biosynthetic transformations.
(B) Catalytic cycle for Fe-dependent halogenases.
Inset graph shows time-dependent 318 nm absor-
bance of the reactive Fe(IV)–oxo species in the
presence of L-Aba-S-CytC2 (red), with extended
half-life in the presence of d3-L-Aba-S-CytC2 sub-
strate (blue).
Subsequent oxidative ligand transfer of
the chlorine atom to the substrate radical
results in the formation of a chlorinated
product and reduction of the active-site
iron to the Fe(II) oxidation state, ready
for the next cycle of catalysis. While the
substrate radical has two potential reac-
tion pathways, oxygen rebound to form
an alcohol and chlorine atom transfer to
form an alkyl halide, chlorination is the
only observed outcome. This is consis-
tent with studies on alkane functionaliza-
tion by inorganic [FeIIIX2L]
+ complexes
(X = Br, Cl; L = tris(2-pyridylmethyl)amine
or tris(N-ethylbenzimidazol-2-ylmethyl)-
amine) (Kojima et al., 1993). In the reac-
tion with alkyl peroxides these species
form [LXFeV = O]2+ intermediates, which
abstract H from the substrate and then
transfer the bound halide back to the gen-
erated substrate radical. The preference
for halide over oxygen transfer is rationalized by lower reduction
potential of halogen atom when compared to hydroxyl radical
(Kojima et al., 1993).
The conserved mechanism of hydrogen atom abstraction by
mononuclear non-heme iron halogenases and dioxygenases
suggests that high-valent Fe(IV)–oxo intermediates are a com-
mon strategy for modification of unactivated carbon centers. It
is tempting to postulate that halogenation may have evolved
from hydroxylation activity by the loss of iron-coordinating
carboxylate ligand and coordination of exogenous halide. Initial
efforts to engineer hydroxylase activity into halogenases by
single mutations at this site have been unsuccessful, showing
that in addition to changes in the iron coordination sphere,
more subtle changes in the active site are also necessary to
switch the reaction manifold.
In addition to their involvement in biosynthesis of halogenated
metabolites, non-heme iron halogenases have also been shown
to participate in the formation of cyclopropane-containing bacte-
rial metabolites. One such transformation is the formation of
coronamic acid. CmaB, a halogenase found in the biosynthetic
gene cluster of this molecule in Pseudomonas syringae (Buell
et al., 2003), chlorinates g-methyl group of L-allo-Ile-S-CmaD
thioester (Vaillancourt et al., 2005a). The product of this reaction,
g-Cl-L-allo-Ile-S-CmaD is then the substrate for the
cyclopropane-forming enzyme CmaC, which catalyzes cyclo-
propane formation through the intramolecular displacement of
chloride by the thioester enolate (Kelly et al., 2007).Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved 103
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The final mechanism of halogen incorporation is via the common
halide oxidation state. Fluoride, chloride and bromide are wide-
spread in the earth’s crust and marine environments (Murphy,
2003; van Pee, 1996), but their direct incorporation into natural
product scaffolds is rare and accounts for a small subset of
halogenated metabolites. Nonetheless, two entirely different
mechanisms for halide incorporation into secondary metabo-
lites—one enzymatic, one nonenzymatic—have been described
in the literature. Each system provides intriguing insights into the
reactivity of halides in Nature.
A well-studied example of a halogenase that incorporates
fluoride anion is the fluorinase from Streptomyces cattleya
(O’Hagan et al., 2002). This enzyme transfers fluoride anion to
the electrophilic 50 carbon atom of S-adenosylmethionine
(SAM) substrate to generate 5-fluoroadenosine, which is then
metabolized in a series of reactions to generate fluoroacetate
and 4-fluorothreonine. The crystal structure of fluorinase reveals
that the enzyme is a hexamer, with the active site positioned at
the interface of two monomer units (Dong et al., 2004). The
extensive contacts between SAM and the protein suggest the
crucial importance of substrate recognition and positioning for
efficient catalysis. Interestingly, the ribose ring of SAM is bound
in a high-energy conformation which is postulated to weaken the
C50–S bond and provide an optimal trajectory for the nucleophilic
substitution reaction. The fluoride ion must also be carefully
prepared by the enzyme for catalysis. Because fluoride’s nucle-
ophilicity is greatly diminished by hydrogen bonding to water,
the enzyme must provide a binding pocket that can desolvate
the ion but still provide sufficient stabilizing interactions. Struc-
tural, thermodynamic, and kinetic studies of the native and mu-
tant proteins suggest that initial desolvation is accomplished by
exchanging two water molecules for an active site serine side-
chain and the backbone amide N–H of the same residue (Zhu
et al., 2007). Subsequent binding of SAM provides the main
Figure 5. Halogenation of Natural Products
via Halide Anion
(A) Incorporation of chloride into 50-chloro-50-de-
oxyadenosine in the biosynthesis of salinospora-
mide A.
(B) Monochlorinated enediyne-derived cyano-
sporasides and sporolides.
(C) Proposed mechanism for nonenzymatic halide
incorporation into enediyne natural products.
energetic driving force to fully desolvate
the fluoride ion, making it a potent nucle-
ophile capable of participating in an SN2-
type reaction with the sulfonium center. It
should be pointed out that, due to the
prohibitively high redox potential of fluo-
ride anion, enzymatic fluorination is lim-
ited to this nonoxidative manifold. This
limitation may rationalize the scarcity of
organofluorine metabolites in nature.
Recently, an analogous SAM-depen-
dent chlorinase was identified as the
enzyme responsible for the incorporation
of chlorine into salinosporamide A
(Figure 5A; Eustaquio et al., 2008). Earlier work on the biosynthe-
sis of this molecule showed that the chloroethyl sidechain was
derived from a sugar precursor (Beer and Moore, 2007). Analysis
of the biosynthetic gene cluster identified a putative chlorinase,
SalL, with 35% identity to the known fluorinase enzyme. Exam-
ination of an engineered salL– strain showed it to be deficient
in salinasporamide A production, though this deficiency could
be overcome by chemical complementation with synthetic 50-
chloro-50-deoxyadenosine (50-ClDA). Structurally, the protein
shows features that reinforce the model of halide desolvation
and nucleophilic displacement. The halide is observed to make
one key H-bonding interaction with the protein to aid in initial
desolvation, and the ion is properly aligned for in-line displace-
ment of methionine to generate 50-ClDA. Biochemical character-
ization of the proteins also showed the predicted synthesis of 50-
ClDA from SAM and chloride ion. Though equilibrium favors the
reverse reaction in vitro, the authors reason that downstream
enzymes likely act in vivo to maintain metabolic flux in the for-
ward direction. Overall, this work describes a novel, chemically
orthogonal route to chlorinated metabolites and provides a
valuable tool for future efforts in metabolic engineering.
Isolation and structural characterization of polycyclic metabo-
lites sporolides (Buchanan et al., 2005) and cyanosporasides (Oh
et al., 2006) from marine actinomycete genus Salinispora
revealed that these compounds contain chlorine in one of two
positions (but never both) on an aromatic ring (Figure 5B). It
has been hypothesized that the complex aromatic framework
of these structures originates from nine-membered enediyne
precursors, where chlorination was postulated to occur during
the aromatization of the enediyne unit (Fenical and Jensen,
2006; Oh et al., 2006). Two lines of recently obtained experimen-
tal evidence strongly support this hypothesis. Sequencing of the
genome of the sporolide producer Salinispora tropica showed
the presence of a 9-membered enediyne polyketide synthase
biosynthetic gene cluster (Udwary et al., 2007). Furthermore,104 Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved
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cyclodeca-1,5-diyn-3-ene confirmed the feasibility of the pro-
posal (Perrin et al., 2007). Slight heating of this molecule in the
presence of a lithium halide and weak acid result in the formation
of 1-halotetrahydronaphthalenes. Kinetic dissection of the re-
action mechanism showed that the rate-limiting step is the for-
mation of the p-benzyne intermediate, which results from the
Bergman cyclization of the precursor. This intermediate is pro-
posed to undergo an unprecedented reaction in which chloride
adds to p-benzyne to give chlorine and an electron pair in a
1,4 arrangement (Figure 5C). Subsequent protonation of the
aromatic ring provides the observed monohalogenated prod-
ucts. This halide addition–protonation sequence invokes
unusual chemistry yet provides a simple explanation for why
1,4-dihalogenated sporolides have not been isolated.
Accounting for New Functional Groups
A number of unique halogen-containing functional groups
cannot be readily explained by systems already characterized.
Further studies of these should shed new light on the scope of
biological halogenation.
The jamaicamide family of natural products exhibits unusual
alkenyl- and alkynyl-halogenations and two predicted halo-
genases (one FADH-dependent, one non-heme-iron dependent)
have been found in the biosynthetic gene cluster (Edwards et al.,
2004). The vinyl chloride functionality is present at a b-methyl
branch along the backbone of the molecule. One hypothesis
for its formation has been put forward (Vaillancourt et al.,
2006), whereby the b-methyl branch is installed according to
a known mechanism (Calderone et al., 2007) to give an a,b-
Figure 6. New Opportunities for Enzymatic
Halogenation
(A) Alternative hypotheses, invoking FADH- or Fe-
dependent halogenases, for the formation of the
alkynyl bromide functionality in jamaicamide.
(B) Natural products with novel halogenated or
halogen-derived functional groups.
unsaturated thioester. Chlorination of the
methyl group followed by isomerization
of the double bond would provide the
vinyl chloride via an alkyl chloride inter-
mediate. The alkynyl bromide could be
formed by two alternative mechanisms
(Figure 6A). Direct halogenation of the ter-
minal alkyne could be realized by the
FADH-dependent halogenase, consistent
with a common synthetic method to gen-
erate bromoalkynes using hypobromous
acid. Alternatively, one cannot rule out a
mechanism in which tribromination of the
terminal methyl group of a fully saturated
starting unit is performed by the non-
heme-iron halogenase. Subsequent dou-
ble dehydrobromination would provide
the observed alkynyl bromide functionality.
Genetic and biochemical characterization
of the system will no doubt provide a satis-
fying answer to this question.
New groups of substrates are suggested by other natural prod-
ucts (Figure 6B). Hectochlorin contains a dichlorinated methylene
group, suggesting radical halogenation of a substrate other than
methyl. The recently described gene cluster for this molecule in-
deed predicts a protein, HctB, whose N-terminal domain shows
high homology to known non-heme-iron halogenases (Ramasw-
amy et al., 2007). Curacin contains a cyclopropane group whose
biosynthesis could be possible via chlorination of a b-methyl
branch (as suggested for jamaicamide) followed by enolate cycli-
zation to the cyclopropane (as shown for coronamic acid). Flavin
halogenases have also been implicated in the biosynthesis of na-
pyradiomycin (Winter et al., 2007) and xanthones (Hornung et al.,
2007), suggesting that the substrate scope of these enzymes
encompasses much more than just amino acids and their deriva-
tives. Continued biochemical characterization of these systems
will provide additional insights into halogenation chemistry as
well as new tools for ongoing efforts in metabolic engineering.
Identification of Novel Metabolites and Gene Clusters
Conserved sequence motifs in both flavin-dependant and mono-
nuclear non-heme-iron halogenases have been exploited for
identification of new halogenated metabolites, as well as cloning
of a gene cluster that encodes production of halogenated
metabolites. A sequence-guided genetic screening strategy
was developed to profile a collection of 550 actinomycetes strain
for their biosynthetic potential (Figure 7A; Hornung et al., 2007).
The screening strategy is based on the assumption that similar
structural elements in natural product scaffolds are produced
by homologous enzymes, and therefore identification of genes
that encode such enzymes can predict the biosyntheticChemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved 105
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(A) Discovery of novel structures following PCR amplification of halogenases from potential producer strains.
(B) Discovery of kutzneride gene cluster following PCR amplification of predicted halogenases.capabilities of the producer. Due to the involvement of flavin-de-
pendent halogenases in the production of a number of com-
pounds of therapeutic importance, genes encoding these tailor-
ing enzymes were selected as an ideal target. PCR-based
screening with a single set of degenerate primers identified the
presence of flavoprotein halogenases in 20% of screened micro-
organisms. Among these, several novel putative halogenases
showed high homology to previously identified enzymes. Inter-
estingly, a number of newly identified enzymes showed no sim-
ilarity to known halogenase subgroups, while preserving re-
quired halogenase sequence elements. To determine the
genetic content surrounding the halogenase gene, further se-
quencing was carried out both upstream and downstream of
the gene. The sequence of these adjacent genes allowed for
the prediction of the natural product class to which the putative
metabolite belongs. The production of halogenated metabolites
was confirmed by heterologous expression of two complete
gene clusters, which led to the identification of the glycopeptide
antibiotic CB2364-1 and the polycyclic xanthone antibiotic
CBS40. These findings confirm that the systematic genetic pro-
filing of bacterial strain collections with flavin halogenase probes
is a powerful technique for natural product discovery.
Recently, degenerate PCR probes targeting both flavin-
dependant and mononuclear non-heme-iron halogenases were
used in identification of the biosynthetic gene cluster encoding106 Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rproduction of antifungal and antimicrobial secondary metabo-
lites kutznerides (Figure 7B). Kutznerides are cyclic hexadepsi-
peptides isolated from soil actinomycete Kutzneria sp. 744
(Broberg et al., 2006; Pohanka et al., 2006). Nine structurally
related structures have thus far been identified, all containing
five nonproteinogenic amino acids and one hydroxy acid. The
presence of two halogenated residues, 6,7-dichlorinated hexa-
hydropyrroloindole in all known kutznerides and g-chloropiper-
azic acid in kutznerides 2 and 8, suggests involvement of
flavin-dependent halogenases in kutznerides biosynthesis. Fur-
thermore, the conserved 2-(1-methylcyclopropyl)glycine residue
in these molecules could be derived via a cryptic halogenation
pathway, involving a non-heme-iron halogenase. We postulated
that the gene cluster encoding the production of kutznerides
could be identified based of the requirement for these two types
of halogenating enzymes. Thus, genomic DNA was screened
with degenerate primer-based PCR probes targeting highly
conserved sequences of both types of halogenases, resulting
in identification of two flavin-dependent and one non-heme-iron
halogenase. Based on the obtained amplicons, specific primers
were designed and used to screen a cosmid library of genomic
DNA to identify a gene cluster consisting of 29 ORFs distributed
along 56 kb region of kutzneria’s genome (Fujimori et al., 2007b).
Distinct roles in kutznerides production have been postulated for
17 ORFs, including all three halogenase genes. The putativeights reserved
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Reviewflavoprotein halogenases KtzQ and KtzR could be involved in
chlorination of electron-rich indole moiety of tryptophan and
g-carbon of g,d-dehydropiperazate. KtzD, homologous to
mononuclear non-heme-iron halogenases, could be involved in
the biosynthesis of methylcyclopropyl glycine moiety. It is postu-
lated that this putative halogenase can chlorinate d-methyl group
of KtzC-bound Ile or allo-Ile. The formed d-chloro-(allo-)Ile-S-
KtzC could then be a substrate for KtzA, a protein homologous
to acyl-CoA dehydrogenase-like proteins. Thioester facilitated
abstraction of the a-proton, followed by the removal of the b-
hydride by the oxidized form of the flavin cofactor, would form
an enamine species which could act as an intramolecular nucle-
ophile to displace chloride and form the cyclopropane. The
resulting imine species could be reduced in turn by the dihydro-
flavin cofactor to provide the tethered amino acid in the correct
oxidation state. This proposed mode of enzymatic cyclopropane
formation awaits biochemical characterization.
Prospects for Metabolic Engineering
An important goal for the field of biosynthesis is the rational
engineering of new metabolites using combinations of enzymes
from distinct biosynthetic pathways. Such efforts could lead to
therapeutics with enhanced potency, optimized pharmacoki-
netic properties, or altogether novel mechanisms. The applica-
tion of halogenating enzymes presents significant challenges in
this area. The haloperoxidase enzymes generally exhibit a broad
substrate scope that could potentially allow them to be shuffled
between pathways. However, this could come at the expense of
selectivity making it difficult to predict or control the outcome of
the reactions.
The non-heme-iron and flavin halogenases offer more selec-
tivity in their chemical transformations, but potentially at the
expense of portability. An early success in their application to
metabolic engineering was presented by Sanchez et al. (San-
chez et al., 2005, 2006). By enlisting tryptophan halogenases
with differing regioselectivities, they were successful in engi-
neering the biosynthesis of analogs of rebeccamycin and the
related indolocarbazole staurosporine. In their work, the en-
zymes responsible for the indolocarbazole core structures
were cloned into an actinomycete host along with combinations
of tailoring enzymes. RebH, the endogenous halogenase
responsible for 7-chlorotryptophan formation, was replaced
with either ThaI or PyrH which generate 6- and 5-chlorotrypto-
phan, respectively. Such swaps were successful in producing
novel patterns of halogenation around the indolocarbazole
core. Moving forward, it will be necessary to identify new halo-
genases and carefully assess their substrate specificity and
product selectivity to identify those best suited for combinatorial
applications. For metabolites biosynthesized on assembly lines,
additional understanding of the protein–protein interactions will
also be needed in order to realize the full potential of metabolic
engineering.
Concluding Remarks
The halogenation of natural product scaffolds allows organisms
to optimize the bioactivity of small molecules for evolutionary
advantage. Nature has adopted a wide variety of chemistries
to perform this task, the particular mechanism being matched
to the electronics of the substrate. The more common one-Chemistry & Band two-electron oxidation of halides are targeted to unactivated
and nucleophilic substrates, respectively. In special circum-
stances, Nature also takes advantage of direct halide incorpora-
tion to halogenate electrophilic sites. Through a variety of exper-
imental approaches, the details of these mechanisms have
become increasingly clear, and this knowledge is now being
used to drive the discovery of new natural products and their
gene clusters, as well as the metabolic engineering of new
metabolites.
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